These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8769227

  • 1. Changing stable heart transplant recipients from Sandimmune to Neoral.
    Dalrymple-Hay M, Meara M, Reynolds L, Backhouse L, Wright D, Holt D, Johnston A, Madden B, Murday A.
    Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
    [No Abstract] [Full Text] [Related]

  • 2. Conversion from Sandimmune to Neoral in stable heart transplant recipients.
    Pethig K, Ruhparwar A, Korn A, Christians U, Wahlers T.
    Transplant Proc; 1996 Aug; 28(4):2287-9. PubMed ID: 8769228
    [No Abstract] [Full Text] [Related]

  • 3. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
    Chapman JR, O'Connell PJ, Bovington KJ, Allen RD.
    Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
    [No Abstract] [Full Text] [Related]

  • 4. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R, Sgrosso JL, Sabbatiello R, Castro C, Ahualli L, Pattin M, Vazquez MC.
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M, Pelletier GB, Tan A, Jesina C, Carrier M.
    J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
    [Abstract] [Full Text] [Related]

  • 7. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C, Laine J, Jalanko H, Leijala M, Hoppu K.
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD, Henson S, Bodziak K, Book BK, Gonin J, Jindal RM, Leapman SB, Milgrom ML, Filo RS.
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract] [Full Text] [Related]

  • 9. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG, Larsen KR, Allermand H, Thayssen P, Jensen SB, Pettersson G.
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract] [Full Text] [Related]

  • 10. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
    Diliz HS, Olivera MA, Kershenobich D, Mercado MA, Orozco H.
    Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
    Grant D, Rochon J, Levy G.
    Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
    Serafinowicz A, Gaciong Z, Baçzkowska T, Durlik M, Lao M.
    Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
    [No Abstract] [Full Text] [Related]

  • 13. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
    Cooney GF, Jeevanandam V, Choudhury S, Feutren G, Mueller EA, Eisen HJ.
    Transplant Proc; 1998 Aug; 30(5):1892-4. PubMed ID: 9723323
    [No Abstract] [Full Text] [Related]

  • 14. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW, Winkler M, Bechstein WO, Oldhafer KJ, Ringe B, Maibücher A, Färber L, Pichlmayr R, Neuhaus P.
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract] [Full Text] [Related]

  • 15. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
    Serafinowicz A, Gaciong Z, Baçzkowska T, Rell K, Lao M, Wałaszewski J.
    Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
    [No Abstract] [Full Text] [Related]

  • 16. Follow-up after conversion to Neoral in stable heart transplant recipients.
    Pethig K, Geiger M, Korn A, Grote M, Christians U, Wahlers T.
    Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
    Cooney GF, Lum BL, Meligeni JA, Dunn SP.
    Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
    [No Abstract] [Full Text] [Related]

  • 18. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
    Hoyer PF, Boekenkamp A, Vester U, Offner G, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218
    [No Abstract] [Full Text] [Related]

  • 19. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.
    Steinmuller D, Dougherty J, Coutee J, Surek D, Swies G, Lewis R.
    Transplant Proc; 1997 Aug; 29(1-2):298-9. PubMed ID: 9123005
    [No Abstract] [Full Text] [Related]

  • 20. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK, Ho YW, Tong KL, Chan WH, Chan A.
    Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.